Eggs used in producing flu vaccine are to be produced year-round for the next four years under a $41 million contract signed by the U.S. government with Sanofi-Aventis. The intent of the government is to maintain a permanent supply of certain types of eggs needed to produce the flu vaccine, rather than rely on seasonal provisions as has been the case. The new plan is designed to allow vaccine production at any time it is needed. Meanwhile, the CDC announced a new formula for distributing the current vaccine to people believed at high risk.
Published in Brief: